The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation

Creative Commons License

Dagklis T., Sen C., Tsakiridis I., Villalain C., Allegaert K., Wellmann S., ...More

JOURNAL OF PERINATAL MEDICINE, vol.50, pp.375-385, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50
  • Publication Date: 2022
  • Doi Number: 10.1515/jpm-2022-0066
  • Journal Name: JOURNAL OF PERINATAL MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.375-385
  • Keywords: corticosteroids, fetal maturation, guideline, pregnancy, preterm delivery, RESPIRATORY-DISTRESS-SYNDROME, PRETERM PREMATURE RUPTURE, NEONATAL OUTCOMES, MULTIPLE COURSES, SINGLE COURSE, BETAMETHASONE, DELIVERY, BIRTH, MORTALITY, THERAPY
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University Affiliated: No

Abstract

This practice guideline follows the mission of the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation, bringing together groups and individuals throughout the world, with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation. In fact, this document provides further guidance for healthcare practitioners on the appropriate use of ACS with the aim to increase the timely administration and avoid unnecessary or excessive use. Therefore, it is not intended to establish a legal standard of care. This document is based on consensus among perinatal experts throughout the world and serves as a guideline for use in clinical practice.